Judith Penkert
Carl Neuberg Str. 1
Hannover, NI 30625, Germany
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Urgent need to recognize that Disease-Causing TP53 variants with atypical penetrance require distinct clinical recommendations.
Journal: Journal of the National Cancer Institute
Published: October 20, 2025
Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 09, 2025
Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2025
A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome.
Journal: Genome medicine
Published: April 15, 2025
Model of care for individuals with rare cancer predisposition syndromes in Germany.
Journal: The Lancet regional health. Europe
Published: January 23, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categories.
Journal: JNCI cancer spectrum
Published: November 07, 2024
Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.
Journal: iScience
Published: June 11, 2024
Research on Rare Diseases in Germany - The cancer predisposition syndrome registry.
Journal: Journal of health monitoring
Published: August 10, 2023
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry.
Journal: Journal of hematology & oncology
Published: June 27, 2022
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.
Journal: The American journal of surgical pathology
Published: April 21, 2022
Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence.
Journal: Frontiers in oncology
Published: November 08, 2020
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 17, 2019
Last Updated: 09/26/2026